By Leslie A. Pappas ( September 7, 2022, 5:27 PM EDT) -- Clarus Therapeutics Inc., a bankrupt manufacturer of a pill that treats low testosterone, received court approval on Wednesday in Delaware bankruptcy court to pay down the interest on its $43 million debt to noteholders and tap into $8.9 million cash on hand to fund the speedy sale of the company's assets....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.